Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Quantitative Evaluation of Dnmt3b Promoter Methylation in Breast Cancer Patients Using Differential High Resolution Melting Analysis



Naghitorabi M1 ; Mohammadi Asl J2 ; Mir Mohammad Sadeghi H1 ; Rabbani M1 ; Jafariandehkordi A3 ; Haghjooye Javanmard S4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  3. 3. Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Research in Pharmaceutical Sciences Published:2013

Abstract

NA methylation plays an important role in carcinogenesis through epigenetic silencing of tumor suppressor genes. Aberrant methylation usually results from changes in the activity of DNA methyltransferases (DNMTs). Some studies show that the overexpression of the DNMTs may lead to aberrant methylation of tumor suppressor genes. Also the overexpression of DNMTs may be related to methylation status of their genes. Due to limited number of studies on DNMT3B promoter methylation, this study was performed to quantitatively measure the methylation level of DNMT3B gene in archival formalin fixed paraffin embedded (FFPE) tissues from breast cancer patients. Using differential high resolution melting analysis (D-HRMA) technology, the methylation level of DNMT3B gene promoter was quantified in 98 breast cancer FFPE tissues and also 10 fresh frozen normal tissue samples. Statistical analyses used for analyzing the correlation between the methylation and clinical variables. All the normal samples were found to be methylated at the DNMT3B promoter (the average methylation level 3.34%). Patients were identified as hypo-methylated (mean methylation level 0.8%), methylated (mean methylation level 2.48%) and hyper-methylated (mean methylation level 10.5%). Statistical analysis showed a significant correlation between the methylation status and the sample type, cancer type and tumor size. Also the methylation level was significantly associated with histologic grade. It is concluded that quantification of DNMT3B promoter methylation might be used as a reliable and sensitive diagnostic and prognostic tool in breast cancer. Also D-HRMA is demonstrated as a rapid and cost effective method for quantitative evaluation of promoter methylation.
Related Docs
View other Related Docs
1. Study of the Role of Sirna Mediated Promoter Methylation in Dnmt3b Knockdown and Alteration of Promoter Methylation of Cdh1, Gstp1 Genes in Mda-Mb -453 Cell Line, Iranian Journal of Pharmaceutical Research (2017)
2. Dna-Methyltransferase 3B 39179 G > T Polymorphism and Risk of Sporadic Colorectal Cancer in a Subset of Iranian Population, Journal of Research in Medical Sciences (2011)
3. Brca1 Promoter Methylation Status in Ovarian Cancer, Laboratory Medicine (2012)
4. Integrative Analysis of Dna Methylation and Gene Expression Through Machine Learning Identifies Stomach Cancer Diagnostic and Prognostic Biomarkers, Journal of Cellular and Molecular Medicine (2023)
5. An Effective Concentration of 5-Aza-Cdr to Induce Cell Death and Apoptosis in Human Pancreatic Cancer Cell Line Through Reactivating Rassf1a and Up-Regulation of Bax Genes, Iranian Journal of Medical Sciences (2018)
6. The Effect of Decitabine on the Expression and Methylation of the Ppp1ca, Btg2, and Pten in Association With Changes in Mir-125B, Mir-17, and Mir-181B in Nalm6 Cell Line, Journal of Cellular Biochemistry (2019)
7. Analysis of Sdc2 Gene Promoter Methylation in Whole Blood for Noninvasive Early Detection of Colorectal Cancer, Journal of Cancer Research and Therapeutics (2022)
8. Analysis of Promoter Methylation, Polymorphism and Expression Profile of Cytotoxic T-Lymphocyte-Associated Antigen-4 in Patients With Gastric Cancer, Journal of Gastrointestinal and Liver Diseases (2014)
Experts (# of related papers)
View all Related Experts
Rasoul Salehi (5)
Mohammad Kazemi (2)
Other Related Docs
9. Promoter Methylation of Matrix Metallopeptidase 9 in Peripheral Blood Mononuclear Cells: A Novel Biomarker in a Promising Source for Noninvasive Colorectal Cancer Diagnosis, Journal of Cancer Research and Therapeutics (2023)
10. Status of Integrin Subunit Alpha 4 Promoter Dna Methylation in Colorectal Cancer and Other Malignant Tumors: A Systematic Review and Meta-Analysis, Research in Pharmaceutical Sciences (2023)
11. Tfpi2 and Ndrg4 Gene Promoter Methylation Analysis in Peripheral Blood Mononuclear Cells Are Novel Epigenetic Noninvasive Biomarkers for Colorectal Cancer Diagnosis, Journal of Gene Medicine (2020)
12. A Comparison Between Full-Cold Pcr/Hrm and Pcr Sequencing for Detection of Mutations in Exon 9 of Pik3ca in Breast Cancer Patients, Applied Biochemistry and Biotechnology (2019)
13. Association Between Colorectal Cancer and the Degree of Itga4 Promoter Methylation in Peripheral Blood Mononuclear Cells, Gene Reports (2022)
14. A Procedure for Dna Methylation Assessment in Osteoporosis-Related Gene Promoters of Umbilical Cord Blood: A Study on the Prospective Epidemiological Research Studies in Iran (Persian) Birth Cohort, BioImpacts (2025)
15. The Frequency of Grasp Gene's Promoter Methylation in Colorectal Cancer Tissue Compared With Healthy Surrounding Tissue, Journal of Isfahan Medical School (2021)
16. Association Between Promoter Methylation and Expression of Thyroid Hormone Receptor Beta (Thrβ) Gene in Patients With Gastric Cancer in an Iranian Population, Journal of Gastroenterology and Hepatology (Australia) (2015)
17. Methylation and Polymorphism in Cdh1 Gene Promoter Among Patients With Diffuse Gastric Cancer, International Journal of Preventive Medicine (2022)
18. Effects of Dna Methylation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis, Archives of Public Health (2022)
19. Regulation of Dna Methylation Machinery by Epi-Mirnas in Human Cancer: Emerging New Targets in Cancer Therapy, Cancer Gene Therapy (2021)
20. Lack of Significance of the Brca2 Promoter Methylation Status in Different Genotypes of the Mthfr A1298c Polymorphism in Ovarian Cancer Cases in Iran, Asian Pacific Journal of Cancer Prevention (2012)
21. Evaluation of Promoter Methylation Status of Mlh1 Gene in Iranian Patients With Colorectal Tumors and Adenoma Polyps, Gastroenterology and Hepatology from Bed to Bench (2017)